Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.998 SEK | 0.00% | -0.20% | -54.64% |
Apr. 25 | NeoDynamics AB Announces CFO Changes | CI |
Apr. 15 | Air Astana Partner with Italy-based Neos | MT |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-54.64% | 3.04M | - | ||
-41.22% | 2.95B | C+ | ||
+18.54% | 1.88B | - | ||
-1.05% | 1.63B | - | ||
+34.11% | 1.34B | B+ | ||
-16.83% | 959M | - | ||
-22.64% | 888M | - | C- | |
+7.44% | 842M | - | ||
-25.93% | 623M | B+ | ||
+10.85% | 513M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NEOD Stock
- Ratings NEOS AB